BioClinica Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioClinica Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7532
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioClinica Inc (BioClinica), formerly Bio-Imaging Technologies, Inc., is a clinical trials services provider. The company’s cloud-based offerings comprise medical image management solutions; electronic data capture (EDC) solutions; clinical data management; clinical trial management systems (CTMS); and eClinical solutions. It also offers cardiac safety monitoring services such as ECG analysis and Digital Holter analysis, TQT study, blood pressure and pulse wave analysis and medical imaging. BioClinica offers its services to pharmaceutical, biotechnology, medical device companies and contract research organizations. The company operates through research locations in in North America, Latin America, Europe and Asia. BioClinica is headquartered in Doylestown, Pennsylvania, the US.

BioClinica Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
BioClinica Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
BioClinica Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
BioClinica Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
BioClinica Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
BioClinica Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
BioClinica Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Clinverse Raises US$3.8 Million In Series B Financing 11
Private Equity 12
Cinven Acquires Bioclinica 12
JLL Partners Completes Acquisition Of BioClinica, Provider Of Clinical Trial Management Solutions, For US$123 Million 13
Partnerships 15
Bioclinica Forms Partnership with ArisGlobal 15
BioClinica Enters into Partnership with arivis 16
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 17
BioClinica Enters Into Technology Integration Agreement With Mirada Medical 18
BioClinica Enters Into Technology Integration Agreement With NextDocs 19
Acquisition 20
BioClinica Acquires MDDX 20
JLL Partners May Sell BioClinica for USD1.3 Billion 21
BioClinica Acquires Blueprint Clinical 22
BioClinica Inc – Key Competitors 23
BioClinica Inc – Key Employees 24
BioClinica Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 29
Strategy And Business Planning 29
Oct 02, 2017: Bioclinica: New Jersey Lt. Governor Kim Guadagno, clients, partners, attend open house 29
Oct 02, 2017: Bioclinica Moves to New Princeton, New Jersey Office in Response to Growth 30
Corporate Communications 31
Apr 11, 2018: Bioclinica Announces Executive Hires and Promotion 31
Nov 29, 2017: Bioclinica Appoints David Herron as CEO 32
Nov 29, 2017: Bioclinica Appoints New Chief Financial Officer, William Hogan 33
Nov 29, 2017: Bioclinica Appoints David Herron as Chief Executive Officer 34
Jun 02, 2017: Bioclinica Introduces Oncology Rescue Studies Team 35
Product News 36
Jun 25, 2018: Bioclinica Introduces Expanded and Enhanced ‘SMART’ Technology Suite Available with Medical Imaging, EDC and IRT Combined 36
Sep 25, 2017: 30 Bioclinica Scientific, Medical, Technology, and Clinical Development Experts Tapped to Present at Upcoming Industry Events 37
May 31, 2017: Bioclinica Introduces Pharmaceutical Industry’s First End-to-End Clinical Financial Lifecycle Platform 39
Other Significant Developments 40
Feb 21, 2018: Bioclinica Delivers Individual Case Safety Report (ICSR) Processing with Quality and Consistency While Crossing One Million Case Milestone in 2017 40
Nov 30, 2017: Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety and Efficacy in Clinical Trials 41
Jul 17, 2017: Bioclinica Announces Cube Has Joined eHealth App xChange 42
Jun 16, 2017: Bioclinica Launches Clean Patient Optics to Accelerate Database Lock and Clinical Trial Timelines 43
Apr 26, 2017: Bioclinica Launches Industry’s Only End-to-End Agile Randomization and Trial Supply Management Platform to Substantially Reduce Trial Timelines and Cos 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
BioClinica Inc, Medical Equipment, Key Facts 2
BioClinica Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
BioClinica Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
BioClinica Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
BioClinica Inc, Deals By Market, 2012 to YTD 2018 9
BioClinica Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Clinverse Raises US$3.8 Million In Series B Financing 11
Cinven Acquires Bioclinica 12
JLL Partners Completes Acquisition Of BioClinica, Provider Of Clinical Trial Management Solutions, For US$123 Million 13
Bioclinica Forms Partnership with ArisGlobal 15
BioClinica Enters into Partnership with arivis 16
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 17
BioClinica Enters Into Technology Integration Agreement With Mirada Medical 18
BioClinica Enters Into Technology Integration Agreement With NextDocs 19
BioClinica Acquires MDDX 20
JLL Partners May Sell BioClinica for USD1.3 Billion 21
BioClinica Acquires Blueprint Clinical 22
BioClinica Inc, Key Competitors 23
BioClinica Inc, Key Employees 24
BioClinica Inc, Other Locations 26
BioClinica Inc, Subsidiaries 26

List of Figures
BioClinica Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
BioClinica Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
BioClinica Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
BioClinica Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[BioClinica Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cancer Research UK-製薬・医療分野:企業M&A・提携分析
    Summary Cancer Research UK (CRUK) is a research institution which offers clinical research services to treat cancer. The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children's ca …
  • CareCloud Corp:医療機器:M&Aディール及び事業提携情報
    Summary CareCloud Corp (CareCloud) is a healthcare technology company that offers cloud healthcare solutions. The company offers cloud-based healthcare IT solutions. It offers revenue cycle management, electronic health records, patient engagement, practice management, and others. CareCloud provides …
  • CFF GmbH & Co KG :企業の戦略・SWOT・財務情報
    CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Laborie Medical Technologies Inc:企業の製品パイプライン分析2018
    Summary Laborie Medical Technologies Inc (Laborie), a subsidiary of Patricia Industries AB, develops and manufactures medical diagnostics and devices. The company offers uroflowmetry, urodynamics, pelvic floor rehabilitation and anorectal manometry products and related consumables. It also provides …
  • Restaurant Brands New Zealand Limited
    Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Lipocine Inc (LPCN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • Xtant Medical Holdings Inc (XTNT)-医療機器分野:企業M&A・提携分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteow …
  • ADX Energy Ltd (ADX):石油・ガス:M&Aディール及び事業提携情報
    Summary ADX Energy Ltd (ADX) is an upstream oil and gas company that carries out energy exploration activities in North Africa and Europe. The company operates through three segments, namely, Tunisia Exploration and Evaluation, Romania Exploration and Evaluation and Italy Exploration and Evaluation. …
  • Vp Plc (VP.):企業の財務・戦略的SWOT分析
    Summary Vp Plc (Vp) is a provider of equipment rental services. The company offers material handling equipment rental for housing, general construction and other industries; equipment for shoring and piling, pipe stoppers, pumps, temporary bridges and excavation support equipment for water, gas, civ …
  • BioLight Israeli Life Sciences Ltd (BOLT):医療機器:M&Aディール及び事業提携情報
    Summary BioLight Israeli Life Sciences Ltd (Bio-Light), formerly Bio Light Israeli Life Sciences Investments Ltd is an ophthalmic company that discovers, develops and commercializes products and product candidates for various ophthalmic conditions. The company invests in managing and commercializing …
  • ERI Bancaire SA:企業の戦略的SWOT分析
    ERI Bancaire SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Carisma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carisma Therapeutics Inc (Carisma Therapeutics), formerly CARMA Therapeutics LLC, is a biotechnology company with focus on the discovery and development of macrophage-based immunotherapeutics for the treatment of cancer. The company exploits its proprietary CAR-macrophage platform to provide …
  • Korean Air Lines Co Ltd:企業の戦略・SWOT・財務情報
    Korean Air Lines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Korean Air Lines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Chromalloy Gas Turbine LLC:戦略・SWOT・企業財務分析
    Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report Summary Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Air Total International SA:企業の戦略的SWOT分析
    Air Total International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Energen Corporation:企業の戦略・SWOT・財務情報
    Energen Corporation - Strategy, SWOT and Corporate Finance Report Summary Energen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mentor Graphics Corporation (MENT):企業の財務・戦略的SWOT分析
    Mentor Graphics Corporation (MENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Onconova Therapeutics Inc (ONTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Onconova Therapeutics Inc (Onconova) is a biopharmaceutical company that discovers and develops small molecule drug candidates for the treatment of cancer. The company’s drug candidates include rigosertib, briciclib and recilisib. It develops drug candidates that target cancer and protect he …
  • HanAll Biopharma Co Ltd (009420):製薬・医療:M&Aディール及び事業提携情報
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a pharmaceutical company that offers drug delivery, biotherapeutics, and small molecule discovery programs. The company develops drugs in therapeutic areas of ophthalmology, immunology, cardiovascular disease, dermat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆